Literature DB >> 32148182

Big Insulin-like Growth Factor 2-Producing Tumor in a Hypoglycemic Dog.

Syunya Noguchi1, Yoshiaki Kubo2, Mami Araki1, Miki Koh1, Yuji Hamamoto2, Kyoichi Tamura3, Hirotada Otsuka1, Akiko Yasuda2, Daigo Azakami4, Masaki Michishita5, Satoshi Soeta1.   

Abstract

A 10-year-old female Papillon dog that had previously developed a mammary tumor was admitted for treatment of a hypoglycemic attack. Blood examination showed severe hypoglycemia and decreased blood insulin concentration. Computed tomography indicated multiple tumors in the cranial and caudal lobes of the right lung. These tumors were resected surgically and diagnosed as pulmonary adenocarcinomas by histopathologic examination. Hypoglycemia was temporarily improved after the resection, but a hypoglycemic event occurred 2 months after the surgery. Immunohistochemistry of the tumor demonstrated the expression of insulin-like growth factor 2 in tumor cells. Western blot analysis revealed the expression of high-molecular-weight (big)-insulin-like growth factor 2 in the tumor region. Insulin-like growth factor 2 mRNA expression was also confirmed in the tumor using reverse transcription-polymerase chain reaction. These findings indicate the diagnosis of non-islet cell tumor-induced hypoglycemia caused by big-insulin-like growth factor 2 produced by the tumor in the dog. This report provides information on differentiating tumors that cause paraneoplastic hypoglycemia.

Entities:  

Keywords:  adenocarcinoma; big-IGF-2; epithelial tumor; hypoglycemia; insulin-like growth factor; lung; non-islet cell tumor hypoglycemia; paraneoplastic syndrome

Mesh:

Substances:

Year:  2020        PMID: 32148182     DOI: 10.1177/0300985820906897

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  1 in total

1.  Rare Presentation of Hypoglycemia in a Patient with Anaplastic Large-Cell Lymphoma.

Authors:  Raed Aldahash
Journal:  Case Rep Endocrinol       Date:  2021-12-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.